1. O’Donnell JC. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research. Value Health 2013;16(Suppl.):S1–3.
2. Redekop K, Mladsi D. The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health 2013;16(Suppl.):S4–9.
3. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers;Trusheim;Nat Rev Drug Discov,2007
4. Interview with Dr. Francis Collins, Director of the Human Genome Project at the National Institutes of Health. Religion Ethics Newsweekly. Available from: http://www.pbs.org/wnet/religionandethics/episodes/june-16-2000/transcript-bob-abernethys-interview-with-dr-francis-collins-director-of-the-human-genome-project-at-the-national-institutes-of-health/15204/. [Accessed July 26, 2013].
5. Garrison LP, Veenstra DL, Carlson RJ, et al. Backgrounder on Pharmacogenomics for the Pharmaceutical and Biotechnology Industries: Basic Science, Future Scenarios, Policy Directions. Report. Pharmaceutical Outcomes Research Policy and Program, Department of Pharmacy, University of Washington, February 2007.